Literature DB >> 28811051

Patient Blood Management in the Intensive Care Unit.

Aryeh Shander1, Mazyar Javidroozi2, Gregg Lobel2.   

Abstract

Patient Blood Management underscores a fundamental shift from a product-centered approach to a patient-centric approach through timely application of evidence-based medical and surgical concepts designed to maintain hemoglobin concentration, optimize hemostasis, and minimize blood loss in an effort to improve patient outcome. In this concept, allogeneic blood transfusion is not viewed as the treatment of default for anemic patients, but one among many treatment modalities that should be weighed based on its merits-potentials risks and benefits-for the individual patient in the context of other alternatives. Patient blood management provides a multidisciplinary framework for patient-centered decision making with strategies focusing on the management of anemia, optimization of coagulation and hemostasis, and utilization of blood conservation modalities. Among the critically ill patients, Patient Blood Management can be particularly effective given the extremely high prevalence of anemia, variable and unjustified transfusion practices, high frequency of coagulation disorders, and avoidable sources of blood loss such as unnecessary diagnostic blood draws. Proper management of anemia-prevention, screening/monitoring, diagnostic workup, and treatment including hematinic agents-is the key to effective implementation of patient blood management. Blood transfusions should be used in accordance of current guidelines, which are supportive of more restrictive transfusion strategies in most critically ill patients. Emerging studies report on the success of Patient Blood Management programs in reducing transfusion utilization, reducing the burden of anemia in patients, and improving patient outcomes including shortened length of hospital stays, less frequency of complications and lower risk of mortality.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Anemia; Critical care; Hemoglobin; Hemostasis; Inflammation; Iron; Mortality; Outcomes; Patient blood management; Transfusion

Mesh:

Year:  2017        PMID: 28811051     DOI: 10.1016/j.tmrv.2017.07.007

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  6 in total

1.  In search of the lost blood.

Authors:  Mazyar Javidroozi; Sajjad Naqvi; Aryeh Shander
Journal:  Blood Transfus       Date:  2020-01       Impact factor: 3.443

Review 2.  Patient Blood Management: a revolutionary approach to transfusion medicine.

Authors:  Massimo Franchini; Giuseppe Marano; Eva Veropalumbo; Francesca Masiello; Ilaria Pati; Fabio Candura; Samantha Profili; Liviana Catalano; Vanessa Piccinini; Simonetta Pupella; Stefania Vaglio; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-05       Impact factor: 3.443

3.  Epidemiology and Associated Factors in Transfusion Management in Intensive Care Unit.

Authors:  Raúl Juárez-Vela; Eva María Andrés-Esteban; Ivan Santolalla-Arnedo; Regina Ruiz de Viñaspre-Hernández; Carmen Benito-Puncel; Ainhoa Serrano-Lázaro; Pilar Marcos-Neira; Alba López-Fernández; Clara Isabel Tejada-Garrido; Juan Luis Sánchez-González; Manuel Quintana-Díaz; José Antonio García-Erce
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

4.  Non-erythropoiesis-stimulating agent, non-iron therapies for the management of anaemia: protocol for a scoping review.

Authors:  Paula Devlin; Amelia Davies; Cory Dugan; Toby Richards; Lachlan F Miles
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 2.692

5.  Predictors associated with mortality of extracorporeal life support therapy for acute heart failure: single-center experience with 679 patients.

Authors:  Sebastian D Sahli; Alexander Kaserer; Donat R Spahn; Markus J Wilhelm; Julia Braun; Maximilian Halbe; Yuliya Dahlem; Muriel A Spahn; Julian Rössler; Bernard Krüger; Francesco Maisano
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

Review 6.  Patient blood management during the COVID-19 pandemic: a narrative review.

Authors:  D M Baron; M Franchini; S M Goobie; M Javidroozi; A A Klein; S Lasocki; G M Liumbruno; M Muñoz; A Shander; D R Spahn; K Zacharowski; P Meybohm
Journal:  Anaesthesia       Date:  2020-05-06       Impact factor: 6.955

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.